147 related articles for article (PubMed ID: 36152343)
41. Soluble epoxide hydrolase inhibitory components from Rheum undulatum and in silico approach.
Jo AR; Kim JH; Yan XT; Yang SY; Kim YH
J Enzyme Inhib Med Chem; 2016; 31(sup2):70-78. PubMed ID: 27555350
[TBL] [Abstract][Full Text] [Related]
42. Phytochemical constituents from Scutellaria baicalensis in soluble epoxide hydrolase inhibition: Kinetics and interaction mechanism merged with simulations.
Liu ZB; Sun CP; Xu JX; Morisseau C; Hammock BD; Qiu F
Int J Biol Macromol; 2019 Jul; 133():1187-1193. PubMed ID: 30980876
[TBL] [Abstract][Full Text] [Related]
43. Natural soluble epoxide hydrolase inhibitors from Alisma orientale and their potential mechanism with soluble epoxide hydrolase.
Zhao WY; Zhang XY; Zhou MR; Tian XG; Lv X; Zhang HL; Deng S; Zhang BJ; Sun CP; Ma XC
Int J Biol Macromol; 2021 Jul; 183():811-817. PubMed ID: 33957203
[TBL] [Abstract][Full Text] [Related]
44. Screening and Biological Evaluation of Soluble Epoxide Hydrolase Inhibitors: Assessing the Role of Hydrophobicity in the Pharmacophore-Guided Search of Novel Hits.
Vázquez J; Ginex T; Herrero A; Morisseau C; Hammock BD; Luque FJ
J Chem Inf Model; 2023 May; 63(10):3209-3225. PubMed ID: 37141492
[TBL] [Abstract][Full Text] [Related]
45. Adamantyl thioureas as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Pitushkin D; Karlov D; Fayzullin RR; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2018 Jul; 28(13):2302-2313. PubMed ID: 29803731
[TBL] [Abstract][Full Text] [Related]
46. Isolation of soluble epoxide hydrolase inhibitor of capsaicin analogs from Capsicum chinense Jacq. cv. Habanero.
Kim JH; Jo YD; Jin CH
Int J Biol Macromol; 2019 Aug; 135():1202-1207. PubMed ID: 31175899
[TBL] [Abstract][Full Text] [Related]
47. Inhibitory Activity of Quercetin 3-
Cho IS; Kim JH; Lin Y; Su XD; Kang JS; Yang SY; Kim YH
Molecules; 2020 Sep; 25(18):. PubMed ID: 32972033
[TBL] [Abstract][Full Text] [Related]
48. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
Gurung AB; Mayengbam B; Bhattacharjee A
Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
[TBL] [Abstract][Full Text] [Related]
49. Identification and optimization of soluble epoxide hydrolase inhibitors with dual potency towards fatty acid amide hydrolase.
Kodani SD; Bhakta S; Hwang SH; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD
Bioorg Med Chem Lett; 2018 Feb; 28(4):762-768. PubMed ID: 29366648
[TBL] [Abstract][Full Text] [Related]
50. Synthesis and structure-activity relationship of piperidine-derived non-urea soluble epoxide hydrolase inhibitors.
Pecic S; Pakhomova S; Newcomer ME; Morisseau C; Hammock BD; Zhu Z; Rinderspacher A; Deng SX
Bioorg Med Chem Lett; 2013 Jan; 23(2):417-21. PubMed ID: 23237835
[TBL] [Abstract][Full Text] [Related]
51. In silico investigation of cycloartane triterpene derivatives from Cimicifuga dahurica (Turcz.) Maxim. roots for the development of potent soluble epoxide hydrolase inhibitors.
Thao NP; Kim JH; Thuy Luyen BT; Dat NT; Kim YH
Int J Biol Macromol; 2017 May; 98():526-534. PubMed ID: 28188798
[TBL] [Abstract][Full Text] [Related]
52. Three-dimensional rational approach to the discovery of potent substituted cyclopropyl urea soluble epoxide hydrolase inhibitors.
Takai K; Chiyo N; Nakajima T; Nariai T; Ishikawa C; Nakatani S; Ikeno A; Yamamoto S; Sone T
Bioorg Med Chem Lett; 2015 Apr; 25(8):1705-1708. PubMed ID: 25800114
[TBL] [Abstract][Full Text] [Related]
53. 1,3-Disubstituted and 1,3,3-trisubstituted adamantyl-ureas with isoxazole as soluble epoxide hydrolase inhibitors.
Burmistrov V; Morisseau C; Danilov D; Harris TR; Dalinger I; Vatsadze I; Shkineva T; Butov GM; Hammock BD
Bioorg Med Chem Lett; 2015 Dec; 25(23):5514-9. PubMed ID: 26520661
[TBL] [Abstract][Full Text] [Related]
54. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
[TBL] [Abstract][Full Text] [Related]
55. 2-Oxaadamant-1-yl Ureas as Soluble Epoxide Hydrolase Inhibitors:
Codony S; Pujol E; Pizarro J; Feixas F; Valverde E; Loza MI; Brea JM; Saez E; Oyarzabal J; Pineda-Lucena A; Pérez B; Pérez C; Rodríguez-Franco MI; Leiva R; Osuna S; Morisseau C; Hammock BD; Vázquez-Carrera M; Vázquez S
J Med Chem; 2020 Sep; 63(17):9237-9257. PubMed ID: 32787085
[No Abstract] [Full Text] [Related]
56. Hybrid Receptor-Bound/MM-GBSA-Per-residue Energy-Based Pharmacophore Modelling: Enhanced Approach for Identification of Selective LTA4H Inhibitors as Potential Anti-inflammatory Drugs.
Appiah-Kubi P; Soliman M
Cell Biochem Biophys; 2017 Mar; 75(1):35-48. PubMed ID: 27914004
[TBL] [Abstract][Full Text] [Related]
57. Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.
Tsai HJ; Hwang SH; Morisseau C; Yang J; Jones PD; Kasagami T; Kim IH; Hammock BD
Eur J Pharm Sci; 2010 Jun; 40(3):222-38. PubMed ID: 20359531
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of soluble epoxide hydrolase by fulvestrant and sulfoxides.
Morisseau C; Pakhomova S; Hwang SH; Newcomer ME; Hammock BD
Bioorg Med Chem Lett; 2013 Jul; 23(13):3818-21. PubMed ID: 23684894
[TBL] [Abstract][Full Text] [Related]
59. Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
Han Y; Huang D; Xu S; Li L; Tian Y; Li S; Chen C; Li Y; Sun Y; Hou Y; Sun Y; Qin M; Gong P; Gao Z; Zhao Y
Eur J Med Chem; 2021 Feb; 212():113028. PubMed ID: 33248848
[TBL] [Abstract][Full Text] [Related]
60. Small Molecule Soluble Epoxide Hydrolase Inhibitors in Multitarget and Combination Therapies for Inflammation and Cancer.
Das Mahapatra A; Choubey R; Datta B
Molecules; 2020 Nov; 25(23):. PubMed ID: 33255197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
